» Pooled-Analysis Of 54 Clinical Studies Shows No Increased Risk Of Heart Attack With Abacavir Therapy
GlaxoSmithKline (NYSE: GSK) (GSK) announced that a review of data from over 14,600 patients in 54 clinical studies showed no increased risk of myocardial infarction associated with the anti-HIV…